THE FEINSTEIN INSTITUTES FOR MEDIC… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1983

Legal Domicile

Principal Officer

MICHAEL J DOWLING

Phone

5163216058

Tax Period

2024-01-01 to 2024-12-31

THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH, founded in 1983, is a major nonprofit in the Medical Research sector that reported $163.3M in total revenue in fiscal year 2024.

Mission

THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH ("THE INSTITUTE") IS THE RESEARCH BRANCH OF NORTHWELL HEALTH ("NORTHWELL"). THROUGH ITS AFFILIATION WITH NORTHWELL, THE INSTITUTE'S MISSION IS TO BRIDGE THE GAP BETWEEN BIOMEDICAL RESEARCH AND PATIENT CARE, ACCESSING HUNDREDS OF THOUSANDS OF PATIENTS IN NORTHWELL'S VARIOUS HOSPITALS, LONG-TERM CARE FACILITIES, TRAUMA CENTERS, HOME HEALTH AGENCIES AND OUTPATIENT FACILITIES. INSTITUTE SCIENTISTS COLLABORATE WITH CLINICIANS THROUGHOUT NORTHWELL TO SHED LIGHT ON BASIC BIOLOGICAL PROCESSES UNDERLYING DISEASE. THIS KNOWLEDGE IS USED TO DEVELOP NEW THERAPIES AND DIAGNOSTICS.

Program Service Accomplishments

Program 1

Expenses: $142,885,557 Revenue: $14,506,430

The Feinstein Institute for Medical Research conducts direct continuous active medical research in the areas of molecular biology, biostatistics, electron microscopy, nuclear physics molecular...

The Feinstein Institute for Medical Research conducts direct continuous active medical research in the areas of molecular biology, biostatistics, electron microscopy, nuclear physics molecular genetics, molecular immunology, animal facility, pediatrics, Gastrointestinal biochemical and PET/Cyclotron activities.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $141,059,017

Program Service Revenue $14,506,430

Investment Income $4,944,064

Other Revenue $2,798,960

TOTAL REVENUE $163,308,471

Expense Breakdown

Grants Paid $0

Salaries & Benefits $118,781,702

Fundraising Expenses $7,655,237

Program Expenses $142,885,557

Other Expenses $44,497,623

TOTAL EXPENSES $163,279,325

Year-over-Year Comparison

	2024	2023	Change
Revenue	$163,308,471	$152,772,247	+0.1%
Expenses	$163,279,325	$150,884,033	+0.1%
Net Income	$29,146	$1,888,214	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

700

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$7,596,207

Total Directors

$1,809,053

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHELE CUSACK	EVP & CFO	0.0	Officer	$0	$85,322	$1,990,193
KEVIN TRACEY	President	50.0	Officer Director	$1,723,661	$85,392	$1,809,053
LAURENCE KRAEMER	EVP, General Counsel & Asst Se	0.0	Officer	$0	$69,777	$1,677,461
RALPH NAPPI	Chairman Emeritus	0.0	Officer	$0	$69,731	$1,067,436
PING WANG	Chief Scientific Officer	50.0	Officer	$997,923	$54,141	$1,052,064
BETTY DIAMOND	Center Head/Autoimmune Disease	50.0	Highest	$744,926	$54,164	$799,090
CHAD BOUTON	VP, Advanced Engineering	50.0	Highest	$654,833	$85,322	$740,155
CHRISTINA BRENNAN	SVP, Clinical Research	50.0	Highest	$663,033	$38,550	$701,583
DOUGLAS NIXON	Karches Family Chair in Transl	50.0	Highest	$628,413	$55,465	$683,878
CATHERINE ALFANO	VP, Cancer Care Mgmt & Rsch	50.0	Highest	$630,068	$38,550	$668,618
BARBARA HRBEK ZUCKER	Chairwoman Emeritus	0.0	Officer Director	$0	$0	$0
LEWIS RANIERI	Co-Chairman	0.0	Officer Director	$0	$0	$0
SCOTT RECHLER	Co-Chairman	0.0	Officer Director	$0	$0	$0
JACK ROSS	Vice Chairman	0.0	Officer Director	$0	$0	$0
ROBERT CATELL	Treasurer	0.0	Officer Director	$0	$0	$0
SUSAN CLASTER	Secretary	0.0	Officer Director	$0	$0	$0
NON COMPENSATED TRUSTEES	SEE SCHEDULE O	0.0	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$163,308,471	$163,279,325	$229,331,844	$29,146
2023	$152,772,247	$150,884,033	$222,810,628	$1,888,214
2022	$136,817,092	$137,105,516	$210,719,887	$-288,424
2021	$147,161,162	$133,748,781	$209,186,011	$13,412,381
2020	$132,965,879	$127,937,115	$183,805,481	$5,028,764
2019	$127,578,675	$123,961,103	$176,775,005	$3,617,572
2018	$115,921,470	$119,836,581	$175,908,874	$-3,915,111

THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH